Substrate | Expressed UGT1A3 | Expressed UGT1A4 | ||||
---|---|---|---|---|---|---|
ApparentKM | Vmax | Vmax/KM | ApparentKM | Vmax | Vmax/KM | |
μM | pmol/min/mg | μl/min/mg (×100) | μM | pmol/min/mg | μl/min/mg (×100) | |
Amines | ||||||
2-Aminobiphenyl | 1521, 1638 | 24, 35 | 2, 2 | 472-a | 450 | 960 |
4-Aminobiphenyl | 1362, 990 | 219, 215 | 16, 22 | 662-a | 570 | 860 |
Cyproheptadine | 267, 212 | 172, 96 | 64, 45 | 81, 43 | 51, 47 | 63, 109 |
Amitriptyline | 250, 283 | 60, 50 | 24, 18 | 170, 128 | 96, 63 | 54, 49 |
Imipramine | 514, 430 | 8, 11 | 2, 3 | 3102-b | 180 | 58 |
Opioids | ||||||
Morphine | 3650, 2910 | 27, 49 | 0.7, 1.7 | NDa,c | ||
Buprenorphine | 61, 48 | 85, 65 | 139, 135 | ND2-a | ||
Norbuprenorphine | 16, 21 | 110, 147 | 690, 700 | ND2-a |
Apparent KM values for the aglycone substrates were determined using 2.0 mM UDP-glucuronic acid. Other assay conditions are described in Materials and Methods. The optimal pH was used for each substrate, as follows: all amines, pH 8.4; buprenorphine, pH 7.0; morphine and norbuprenorphine, pH 8.0. Results are expressed as the values obtained using cell homogenates from two different transfections.
↵2-a Data taken from Green and Tephly (1996).
↵2-b Data taken from Green et al. (1995).
2-c ND, compounds are not substrates.